Phar­ma brands spent $3.9B on TV ads in 2021, led by Sanofi, Re­gen­eron’s Dupix­ent and No­vo Nordisk’s Ry­bel­sus

Third-place is un­fa­mil­iar ter­ri­to­ry for Ab­b­Vie’s block­buster drug Hu­mi­ra – even when it comes to TV ad spend­ing. But that’s where the drug end­ed up in 2021 af­ter Ab­b­Vie switched up Hu­mi­ra’s typ­i­cal­ly top-spend bud­get and re­al­lo­cat­ed some of its spend­ing to new­er sib­ling brands Rin­voq and Skyrizi.

The new No. 1 this year is Dupix­ent, Sanofi and Re­gen­eron’s treat­ment ap­proved in in­di­ca­tions like asth­ma and eczema, ac­cord­ing to da­ta from re­al­time TV ad track­er iS­pot.tv.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER